Hyperthermic intraperitoneal chemotherapy (HIPEC) is a type of advanced regional perfusion cancer therapy. HIPEC occurs during abdominal surgery when the surgeon has access to the entire abdomen.
Typically, the surgeon will first perform cytoreductive surgery (CRS), where the goal is to surgically remove all visible cancer nodules. HIPEC is then performed by filling the open abdomen with heated chemotherapy solution. The HIPEC fluid is allowed to bathe the peritoneal surfaces for one to two hours.
CRS aims to surgically remove all visible cancer nodules. HIPEC then treats small cancer nodules or microscopic (invisible) cancer cells that may be left behind after CRS.
Malignant peritoneal tumors in children are rare but commonly associated with disease progression and poor outcomes. HIPEC procedures have been used for years to treat adult peritoneal carcinomatosis; it has recently been modified for pediatric use to treat children and teens with abdominal cancers.
We treat the following cancers with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy:
- Desmoplastic small round cell tumor (DSRCT) — A rare but aggressive malignant tumor occurring primarily in the abdomen.
- Sarcomas that are spread along the peritoneal surfaces of the abdomen — Alveolar type rhabdomyosarcoma is an example of a sarcoma that may act this way.
- Late-stage and advanced cancers of the peritoneal cavity or inner-abdominal lining — These are more typical in adults, but if present in children, HIPEC can treat advanced cancers of the abdomen, including cancers of the colon, stomach, appendix, and ovaries. It may be an option for children whose abdominal cancers have been resistant to other treatments.
- Metastases — Sometimes called secondary cancers, metastases are cancers that have spread from the original tumor to other parts of the body. Some are too advanced to be removed with surgery. But when peritoneal metastases are confined to the abdomen, HIPEC may be an option.
Is HIPEC right for my child?
When used in combination with cytoreductive surgery, HIPEC works best for children whose cancers are confined or have only spread to the abdomen's inner lining.
Your child’s care team will talk with you about HIPEC if they believe the surgery could benefit their cancer recovery journey.
Outcomes depend on your child’s:
- Cancer stage.
- Cancer type.
- Extent of cancer spread before surgery.
- Overall health.
In cytoreduction surgery (CRS), the surgeon tries to remove all visible nodules or tumors. This may involve removing part of the colon, omentum (a fatty tissue covering the abdominal organs), or other affected tissues.
Surgeons may use an open or closed procedure, depending on the location of the tumor and the extent of cancer spread.
After CRS, surgeons apply a potent dose of heated chemotherapy directly to the abdominal cavity.
Benefits of HIPEC may include:
- It can effectively treat early-stage cancers with little spread.
- It may have fewer side effects than chemotherapy given intravenously.
- It takes advantage of the access to the open abdomen that occurs during surgery, allowing the doctors to directly apply chemotherapy to the cancerous areas.
For more aggressive or advanced cancers, HIPEC can be combined with other therapies, such as standard IV chemo, and may provide benefit in treating remaining cancer cells.